Project Grant HT94252510431
Award Date
9/1/25
Completion Date
8/31/28
Dollars Obligated
$2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Gardena, CA 90248, USA
Similar Awards
This $598,894.00 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of a novel point-of-care rejection and immunosuppression monitoring assay (PRIMA) for vascularized composite allotransplantation (VCA). The primary recipient, Intelligent Optical Systems, Inc., is a manufacturer of optical sensing and instrumentation technologies that specializes in developing innovative medical...
The Department of Defense's Defense Health Agency awarded a $1,999,583 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to IRR Inc., a for-profit organization located in Santa Barbara, CA. The purpose of this early-stage proof-of-concept study is to evaluate a fixed-dose combination therapy in a high-fidelity porcine model of severe polytrauma. The grant period of performance runs from July 1, 2025 to June 30, 2027. The Military Medical Research and...
The federal Project Grant award of $391,743.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Oregon Health & Science University (OHSU). The award is for the development of a "compact, high resolution, 3D optical imager for anterior eye injury and disease." This research aims to advance innovative medical imaging technologies that can transform healthcare for military service members, veterans, and the...
This $426,400 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at the University of Chicago to conduct nanoscale structural and molecular mapping of the optic nervous system following ocular blast. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing understanding of the impact of ocular blast injuries on the nervous system. The award...
This $1,097,466 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of portable integrated optic biosensors. These biosensors are intended to help identify early indications of potential loss of native tissue in the reconstruction of complex upper extremity amputations. The 2-year grant awarded to the Metis Foundation, a non-profit research organization, will fund the research, development, and...
The Department of Defense's Defense Health Agency awarded a $1,158,179.00 Project Grant to The Ohio State University under the Military Medical Research and Development program (CFDA 12.420) to deliver a sustained therapeutic protein cocktail delivery system to prevent vision loss after ocular trauma. The project aims to develop innovative treatments for military service members and veterans by conducting basic, translational, and clinical research. As a sub-award under this grant, the...
The Defense Health Agency awarded a $1,061,440 Project Grant to the University of South Florida (USF) on September 1, 2023 under the Military Medical Research and Development (CFDA 12.420) program. This 3-year grant will support USF's development of an artificial cornea and sensor-based continuous intraocular pressure (IOP) monitoring system to treat patients with cornea blindness secondary to war-related ocular injuries. The products and services to be delivered through this grant include...
The Defense Health Agency awarded a $498,896 Project Grant through the Military Medical Research and Development program (CFDA 12.420) to The Schepens Eye Research Institute, Inc. in Boston, MA. The grant supports a 2-year research project investigating the use of noninvasive transpalpebral electrical stimulation as a therapy for combat-related corneal trauma. As an experienced performer of prior federal grants from agencies like the NIH, DoD, and Army, the non-profit Schepens Eye Research...
The Defense Health Agency awarded a $1,466,706 Project Grant to The Schepens Eye Research Institute, Inc. under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective September 1, 2025 through August 31, 2028, will fund research on "Topical Oxygen for Pan-Ocular Protection (TOPP) Against Severe Chemical Injury". The Schepens Eye Research Institute, a non-profit organization affiliated with Harvard Medical School, will conduct preclinical and...
The Department of Defense's Defense Health Agency has awarded a $4,876,076 Project Grant to Washington University to develop a novel point-of-care multiplex device for classifying molecular phenotypes of acute respiratory distress syndrome and sepsis. This research falls under the Military Medical Research and Development (CFDA 12.420) program, which supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The grant has a performance...